From gene targeting to genome editing: Transgenic animals applications and beyond

Anais da Academia Brasileira de Ciencias

Volumn 87, Issue 2, 2015, Pages 1323-1348

  Rocha Martins, Maurício ^a   Cavalheiro, Gabriel R ^a   Matos Rodrigues, Gabriel E ^a   Martins, Rodrigo Alves Portela ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cre LoxP; CRISPR Cas9; DNA repair; Homologous recombination; TALEN; ZFN

Indexed keywords

ZINC FINGER PROTEIN;

ANIMAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE TARGETING; GENETIC ENGINEERING; GENETICS; MOUSE; PROCEDURES; RAT; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; GENE TARGETING; GENETIC ENGINEERING; MICE; RATS; ZINC FINGERS;

EID: 84942124526     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/0001-3765201520140710     Document Type: Article

References (190)

1. Adams D et al. 2013. Bloomsbury report on mouse embryo phenotyping: recommendations from the IMPC workshop on embryonic lethal screening. Dis Model Mech 6(3): 571-579.
2. Adams MD et al. 2000. The genome sequence of Drosophila melanogaster. Science 287(5461): 2185-2195.
3. Ahn S and Joyner AL. 2004. Dynamic changes in the response of cells to positive hedgehog signaling during mouse limb patterning. Cell 118(4): 505-516.
4. Anguela XM et al. 2013. Robust ZFN-mediated genome editing in adult hemophilic mice. Blood 122(19): 3283-3287.
5. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA and Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315(5819): 1709-1712.
6. Beadle GW and Tatum EL. 1941. Genetic Control of Biochemical Reactions in Neurospora. Proc Natl Acad Sci USA 27(11): 499-506.
7. Bedell VM et al. 2012. In vivo genome editing using a high-efficiency TALEN system. Nature 491(7422): 114-118.
8. Beerli RR, Dreier B and Barbas CF. 2000. Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci USA 97(4): 1495-1500.
9. Bhakta MS et al. 2012. Highly active zinc-finger nucleases by extended modular assembly. Genome Res 23(3): 530-538.
10. Bibikova M, Carroll D, Segal DJ, Trautman JK, Smith J, Kim YG and Chandrasegaran S. 2001. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol 21(1): 289-297.
11. Bibikova M, Golic M, Golic KG and Carroll D. 2002. Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics 161(3): 1169-1175.
12. Bitinaite J, Wah DA, Aggarwal AK and Schildkraut I. 1998. FokI dimerization is required for DNA cleavage. Proc Natl Acad Sci USA 95(18): 10570-10575.
13. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A and Bonas U. 2009. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326(5959): 1509-1512.
14. Bolotin A, Quinquis B, Sorokin A and Ehrlich SD. 2005. Clustered regularly interspaced short palindrome repeats (Crisprs) have spacers of extrachromosomal origin. Microbiology 151(8): 2551-2561.
15. Bowman AN, Van Amerongen R, Palmer TD and Nusse R. 2013. Lineage tracing with Axin2 reveals distinct developmental and adult populations of Wnt/beta-cateninresponsive neural stem cells. Proc Natl Acad Sci USA 110(18): 7324-7329.
16. Bradley A et al. 2012. The mammalian gene function resource: the International Knockout Mouse Consortium. Mamm Genome 23(9-10): 580-586.
17. Branda CS and Dymecki SM. 2004. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6(1): 7-28.
18. Brinster RL, Chen HY, Messing A, Van Dyke T, Levine AJ and Palmiter RD. 1984. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 37(2): 367-379.
19. Brinster RL, Chen HY, Trumbauer M, Senear AW, Warren R and Palmiter RD. 1981. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 27(1 Pt 2): 223-231.
20. Brinster RL, Chen HY, Warren R, Sarthy A and Palmiter RD. 1982. Regulation of metallothionein--thymidine kinase fusion plasmids injected into mouse eggs. Nature 296(5852): 39-42.
21. Brown AJ et al. 2013. Whole-rat conditional gene knockout via genome editing. Nat Methods 10(7): 638-640.
22. Buchholz F, Ringrose L, Angrand PO, Rossi F and Stewart AF. 1996. Different thermostabilities of FLP and cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res 24(21): 4256-4262.
23. Capecchi MR. 1989. Altering the genome by homologous recombination. Science 244(4910): 1288-1292.
24. Capecchi MR. 2005. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 6(6): 507-512.
25. Carbery ID, Ji D, Harrington A, Brown V, Weinstein EJ, Liaw L and Cui X. 2010. Targeted genome modification in mice using zinc-finger nucleases. Genetics 186(2): 451-459.
26. Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ and Voytas DF. 2010. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186(2): 757-761.
27. Clarke AR, Maandag ER, Van Roon M, Van der Lugt NM, Van der Valk M, Hooper ML, Berns A and Te Riele H. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359(6393): 328-330.
28. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA and Zhang F. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121): 819-823.
29. Cradick TJ, Fine EJ, Antico CJ and Bao G. 2013. Crispr/ Cas9 systems targeting beta-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res 41(20): 9584-9592.
30. Crick FH. 1958. On protein synthesis. Symp Soc Exp Biol 12: 138-163.
31. Daimon T, Kiuchi T and Takasu Y. 2013. Recent progress in genome engineering techniques in the silkworm, bombyx mori. Dev Growth Differ 56(1): 14-25.
32. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J and Charpentier E. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471(7340): 602-607.
33. Deveau H, Barrangou R, Garneau JE, Labonte J, Fremaux C, Boyaval P, Romero DA, Horvath P and Moineau S. 2008. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 190(4): 1390-1400.
34. Dickinson DJ, Ward JD, Reiner DJ and Goldstein B. 2013. engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat Methods 10(10): 1028-1034.
35. Doetschman T, Gregg RG, Maeda N, Hooper ML, Melton DW, Thompson S and Smithies O. 1987. Targetted correction of a mutant Hprt gene in mouse embryonic stem cells. Nature 330(6148): 576-578.
36. Doyon Y, Vo TD, Mendel MC, Greenberg SG, Wang J, Xia DF, Miller JC, Urnov FD, Gregory PD and Holmes MC. 2010. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods 8(1): 74-79.
37. Engler C, Kandzia R and Marillonnet S. 2008. A one pot, one step, precision cloning method with high throughput capability. PLoS One 3(11): e3647.
38. Favaro R et al. 2009. Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci 12(10): 1248-1256.
39. Fei JF, Schuez M, Tazaki A, Taniguchi Y, Roensch K and Tanaka EM. 2014. CRISPR-mediated genomic deletion of Sox2 in the axolotl shows a requirement in spinal cord neural stem cell amplification during tail regeneration. Stem Cell Reports 3(3): 444-459.
40. Flowers GP, Timberlake AT, Mclean KC, Monaghan JR and Crews CM. 2014. Highly efficient targeted mutagenesis in axolotl using Cas9 RNA-guided nuclease. Development 141(10): 2165-2171.
41. Folger K, Thomas K and Capecchi MR. 1984. Analysis of homologous recombination in cultured mammalian cells. Cold Spring Harb Symp Quant Biol 49: 123-138.
42. Folger KR, Wong EA, Wahl G and Capecchi MR. 1982. Patterns of integration of DNA microinjected into cultured mammalian cells: evidence for homologous recombination between injected plasmid DNA molecules. Mol Cell Biol 2(11): 1372-1387.
43. Forni PE et al. 2006. High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly. J Neurosci 26(37): 9593-9602.
44. Frock RL, HU J, Meyers RM, Ho YJ, Kii E and Alt FW. 2015. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat Biotechnol 33(2): 179-186.
45. Fu Y, Sander JD, Reyon D, Cascio VM and Joung JK. 2014. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32(3): 279-284.
46. Fujihara Y and Ikawa M. 2014. CRISPR/Cas9-Based Genome editing in Mice by Single Plasmid Injection. Methods enzymol 546: 319-336.
47. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H and Hennighausen L. 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91(20): 9302-9306.
48. Gabriel R et al. 2011. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 29(9): 816-823.
49. Gaj T, Guo J, Kato Y, Sirk SJ and Barbas CF. 2012. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods 9(8): 805-807.
50. Garneau JE, Dupuis ME, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadan AH and Moineau S. 2010. The CRISPR/ Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468(7320): 67-71.
51. Gates CA and Cox MM. 1988. FLP recombinase is an enzyme. Proc Natl Acad Sci USA 85(13): 4628-4632.
52. Golic KG and Lindquist S. 1989. The FLP recombinase of yeast catalyzes site-specific recombination in the Drosophila genome. Cell 59(3): 499-509.
53. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA and Ruddle FH. 1980. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 77(12): 7380-7384.
54. Gratz SJ, Cummings AM, Nguyen JN, Hamm DC, Donohue LK, Harrison MM, Wildonger J and O'Connor-Giles KM. 2013. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 194(4): 1029-1035.
55. Greisman HA and Pabo CO. 1997. A general strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites. Science 275(5300): 657-661.
56. Grindley ND, Whiteson KL and Rice PA. 2006. Mechanisms of site-specific recombination. Annu Rev Biochem 75: 567-605.
57. Guo X, Zhang T, Hu Z, Zhang Y, Shi Z, Wang Q, Cui Y, Wang F, Zhao H and Chen Y. 2014. efficient RNA/ Cas9-mediated genome editing in Xenopus tropicalis. Development 141(3): 707-714.
58. Hammer RE, Pursel VG, Rexroad Jr CE, Wall RJ, Bolt DJ, Ebert KM, Palmiter RD and Brinster RL. 1985. Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315(6021): 680-683.
59. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M and Taketo MM. 1999. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 18(21): 5931-5942.
60. Harrison MM, Jenkins BV, O'Connor-Giles KM and Wildonger J. 2014. A CRISPR view of development. Genes Dev 28(17): 1859-1872.
61. Hayashi S, Tenzen T and McMahon AP. 2003. Maternal inheritance of Cre activity in a Sox2Cre deleter strain. Genesis 37(2): 51-53.
62. He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G and Pandolfi PP. 1997. Acute leukemia with promyelocytic features in PML/ RARalpha transgenic mice. Proc Natl Acad Sci USA 94(10): 5302-5307.
63. Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC and Cannon PM. 2010. Human hematopoietic stem/ progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 28(8): 839-847.
64. Hsu PD et al. 2013. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31(9): 827-832.
65. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR and Joung JK. 2013. efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31(3): 227-229.
66. Ishino Y, Shinagawa H, Makino K, Amemura M and Nakata A. 1987. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in escherichia Coli, and identification of the gene product. J Bacteriol 169(12): 5429-5433.
67. Jao LE, Wente SR and Chen W. 2013. efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc Natl Acad Sci USA 110(34): 13904-13909.
68. Jensen P and Dymecki SM. 2014. essentials of recombinase-based genetic fate mapping in mice. Methods Mol Biol 1092: 437-454.
69. Jiang W, Zhou H, BI H, Fromm M, Yang B and Weeks DP. 2013. Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in arabidopsis, tobacco, sorghum and rice. Nucleic Acids Res 41(20): e188.
70. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA and Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096): 816-821.
71. Joyner AL, Skarnes WC and Rossant J. 1989. Production of a mutation in mouse en-2 gene by homologous recombination in embryonic stem cells. Nature 338(6211): 153-156.
72. Kawase E, Suemori H, Takahashi N, Okazaki K, Hashimoto K and Nakatsuji N. 1994. Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int J Dev Biol 38(2): 385-390.
73. Kim H and Kim JS. 2014. A guide to genome engineering with programmable nucleases. Nat Rev Genet 15(5): 321-334.
74. Kim Y et al. 2013a. A library of TAL effector nucleases spanning the human genome. Nat Biotechnol 31(3): 251-258.
75. Kim YG, Cha J and Chandrasegaran S. 1996. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA 93(3): 1156-1160.
76. Kim YG and Chandrasegaran S. 1994. Chimeric restriction endonuclease. Proc Natl Acad Sci USA 91(3): 883-887.
77. Kim YK, Wee G, Park J, Kim J, Baek D, Kim JS and Kim VN. 2013b. TALEN-based knockout library for human micro RNAs. Nat Struct Mol Biol 20(12): 1458-1464.
78. King MC and Wilson AC. 1975. evolution at two levels in humans and chimpanzees. Science 188(4184): 107-116.
79. Kiskinis E et al. 2014. Pathways disrupted in human Als motor neurons identified through genetic correction of mutant Sod1. Cell Stem Cell 14(6): 781-795.
80. Koller BH, Hagemann LJ, Doetschman T, Hagaman JR, Huang S, Williams PJ, First NL, Maeda N and Smithies O. 1989. Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci USA 86(22): 8927-8931.
81. Koller BH, Marrack P, Kappler JW and Smithies O. 1990. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 248(4960): 1227-1230.
82. Konermann S, Brigham MD, Trevino AE, Hsu PD, Heidenreich M, Cong L, Platt RJ, Scott DA, Church GM and Zhang F. 2013. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500(7463): 472-476.
83. Koscielny G et al. 2014. The International Mouse Phenotyping Consortium Web Portal, a unified point of access for knockout mice and related phenotyping data. Nucleic Acids Res 42(Database issue): D802-809.
84. Krentz NA, Nian C and Lynn FC. 2014. TALEN/CRISPR-Mediated eGFP Knock-In Add-On at the OCT4 Locus Does Not Impact Differentiation of Human embryonic Stem Cells towards endoderm. PLoS One 9(12): e114275.
85. Lagace DC et al. 2007. Dynamic contribution of nestin-expressing stem cells to adult neurogenesis. J Neurosci 27(46): 12623-12629.
86. Lakso M, Sauer B, Mosinger Jr B, Lee EJ, Manning RW, YU SH, Mulder KL and Westphal H. 1992. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89(14): 6232-6236.
87. Lanio T, Jeltsch A and Pingoud A. 2000. On the possibilities and limitations of rational protein design to expand the specificity of restriction enzymes: a case study employing ecoRV as the target. Protein eng 13(4): 275-281.
88. Lao Z, Raju GP, Bai CB and Joyner AL. 2012. Mastr: a technique for mosaic mutant analysis with spatial and temporal control of recombination using conditional floxed alleles in mice. Cell Rep 2(2): 386-396.
89. Lee AY and Lloyd KC. 2014. Conditional targeting of Ispd using paired Cas9 nickase and a single DNA template in mice. FEBS Open Bio 4: 637-642.
90. Levine M and Tjian R. 2003. Transcription regulation and animal diversity. Nature 424(6945): 147-151.
91. Lewandoski M. 2001. Conditional control of gene expression in the mouse. Nat Rev Genet 2(10): 743-755.
92. Lewandoski M and Martin GR. 1997. Cre-mediated chromosome loss in mice. Nat Genet 17(2): 223-225.
93. Li C, Qi R, Singleterry R, Hyle J, Balch A, LI X, Sublett J, Berns H, Valentine M, Valentine V and Sherr CJ. 2014. Simultaneous gene editing by injection of m RNAs encoding transcription activator-like effector nucleases into mouse zygotes. Mol Cell Biol 34(9): 1649-1658.
94. Li H et al. 2011. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475(7355): 217-221.
95. Li HL et al. 2014. Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9. Stem Cell Reports.
96. Liu P, Long L, Xiong K, YU B, Chang N, Xiong JW, Zhu Z and Liu D. 2014. Heritable/conditional genome editing in C. elegans using a CRISPR-Cas9 feeding system. Cell Res 24(7): 886-889.
97. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M and Nagy A. 1999. Z/AP, a double reporter for cre-mediated recombination. Dev Biol 208(2): 281-292.
98. Long C, McAnally JR, Shelton JM, Mireault AA, Bassel-Duby R and Olson EN. 2014. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline Dna. Science 345(6201): 1184-1188.
99. Loonstra A, Vooijs M, Beverloo HB, Allak BA, Van Drunen E, Kanaar R, Berns A and Jonkers J. 2001. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98(16): 9209-9214.
100. Lovell-Badge R and Robertson E. 1990. XY female mice resulting from a heritable mutation in the primary testis-determining gene, TDY. Development 109(3): 635-646.
101. Low Be, Krebs MP, Joung JK, Tsai SQ, Nishina PM and Wiles MV. 2013. Correction of the Crb1rd8 allele and retinal phenotype in C57BL/6N mice via TALEN-mediated homology-directed repair. Invest Ophthalmol Vis Sci 55(1): 387-395.
102. Ma M, Zhao K, WU W, Sun R and Fei J. 2014. Dynamic expression of N-myc in mouse embryonic development using an enhanced green fluorescent protein reporter gene in the N-myc locus. Dev Growth Differ 56(2): 152-160.
103. Ma S, Chang J, Wang X, Liu Y, Zhang J, Lu W, Gao J, Shi R, Zhao P and Xia Q. 2014. CRISPR/Cas9 mediated multiplex genome editing and heritable mutagenesis of BmKu70 in Bombyx mori. Sci Rep 4: 4489.
104. Ma Y, Shen B, Zhang X, Lu Y, Chen W, Ma J, Huang X and Zhang L. 2014. Heritable multiplex genetic engineering in rats using CRISPR/Cas9. PLoS One 9(3): e89413.
105. Ma Y, Zhang X, Shen B, Lu Y, Chen W, Ma J, Bai L, Huang X and Zhang L. 2013. Generating rats with conditional alleles using CRISPR/Cas9. Cell Res 24(1): 122-125.
106. Macpherson D, Sage J, Kim T, Ho D, Mclaughlin ME and Jacks T. 2004. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 18(14): 1681-1694.
107. Maeder ML et al. 2013. Targeted DNA demethylation and activation of endogenous genes using programmable Tale-Tet1 fusion proteins. Nat Biotechnol 31(12): 1137-1142.
108. Maeder ML et al. 2008. Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell 31(2): 294-301.
109. Mahon KA, Chepelinsky AB, Khillan JS, Overbeek PA, Piatigorsky J and Westphal H. 1987. Oncogenesis of the lens in transgenic mice. Science 235(4796): 1622-1628.
110. Mali P, Yang L, Esvelt KM, Aach J, Guell M, Dicarlo JE, Norville JE and Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339(6121): 823-826.
111. Mansour SL, Thomas KR and Capecchi MR. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336(6197): 348-352.
112. Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78(12): 7634-7638.
113. Mazeyrat S, Saut N, Grigoriev V, Mahadevaiah SK, Ojarikre OA, Rattigan A, Bishop C, Eicher EM, Mitchell MJ and Burgoyne PS. 2001. A Y-encoded subunit of the translation initiation factor Eif2 is essential for mouse spermatogenesis. Nat Genet 29(1): 49-53.
114. Mcginnis W and Krumlauf R. 1992. Homeobox genes and axial patterning. Cell 68(2): 283-302.
115. Mcleod M, Craft S and Broach JR. 1986. Identification of the crossover site during FLP-mediated recombination in the Saccharomyces cerevisiae plasmid 2 microns circle. Mol Cell Biol 6(10): 3357-3367.
116. Meckler JF et al. 2013. Quantitative analysis of TALE-DNA interactions suggests polarity effects. Nucleic Acids Res 41(7): 4118-4128.
117. Mendenhall EM, Williamson KE, Reyon D, Zou JY, Ram O, Joung JK and Bernstein BE. 2013. Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol 31(12): 1133-1136.
118. Meyer M, De Angelis MH, Wurst W and Kuhn R. 2010. Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases. Proc Natl Acad Sci USA 107(34): 15022-15026.
119. Miller JC et al. 2007. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25(7): 778-785.
120. Miller JC et al. 2010. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29(2): 143-148.
121. Miyanari Y, Ziegler-Birling C and Torres-Padilla ME. 2013. Live visualization of chromatin dynamics with fluorescent TALEs. Nat Struct Mol Biol 20(11): 1321-1324.
122. Moehle EA, Rock JM, Lee YL, Jouvenot Y, Dekelver RC, Gregory PD, Urnov FD and Holmes MC. 2007. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 104(9): 3055-3060.
123. Mojica FJ, Diez-Villasenor C, Soria E and Juez G. 2000. Biological significance of a family of regularly spaced repeats in the genomes of archaea, bacteria and mitochondria. Mol Microbiol 36(1): 244-246.
124. Mojica FJ, Diez-Villasenor C, Garcia-Martinez J and Soria E. 2005. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol evol 60(2): 174-182.
125. Moscou MJ and Bogdanove AJ. 2009. A simple cipher governs DNA recognition by TAL effectors. Science 326(5959): 1501.
126. Niu Y et al. 2014. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 156(4): 836-843.
127. Okabe M, Ikawa M, Kominami K, Nakanishi T and Nishimune Y. 1997. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 407(3): 313-319.
128. Orban PC, Chui D and Marth JD. 1992. Tissue-and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89(15): 6861-6865.
129. Osborn MJ et al. 2013. TALEN-based gene correction for epidermolysis bullosa. Mol Ther 21(6): 1151-1159.
130. Palmiter RD, Brinster RL, Hammer RE, Trumbauer Me, Rosenfeld MG, Birnberg NC and Evans RM. 1982. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300(5893): 611-615.
131. Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA and Liu DR. 2013. High-throughput profiling of off-target Dna cleavage reveals Rna-programmed Cas9 nuclease specificity. Nat Biotechnol 31(9): 839-843.
132. Perez EE et al. 2008. establishment of Hiv-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26(7): 808-816.
133. Platt RJ et al. 2014. Crispr-Cas9 knockin mice for genome editing and cancer modeling. Cell 159(2): 440-455.
134. Pourcel C, Salvignol G and Vergnaud G. 2005. Crispr elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151(Pt 3): 653-663.
135. Qiu Z et al. 2013. High-efficiency and heritable gene targeting in mouse by transcription activator-like effector nucleases. Nucleic Acids Res 41(11): e120.
136. Ramirez CL et al. 2008. Unexpected failure rates for modular assembly of engineered zinc fingers. Nat Methods 5(5): 374-375.
137. Ren SY, Pasqualetti M, Dierich A, Le Meur M and Rijli FM. 2002. A Hoxa2 mutant conditional allele generated by Flp-and Cre-mediated recombination. Genesis 32(2): 105-108.
138. Ren X et al. 2013. Optimized gene editing technology for Drosophila melanogaster using germ line-specific Cas9. Proc Natl Acad Sci USA 110(47): 19012-19017.
139. Romer P, Hahn S, Jordan T, Strauss T, Bonas U and Lahaye T. 2007. Plant pathogen recognition mediated by promoter activation of the pepper Bs3 resistance gene. Science 318(5850): 645-648.
140. Sander JD et al. 2010. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nat Methods 8(1): 67-69.
141. Sander JD and Joung JK. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32(4): 347-355.
142. Sauer B and Henderson N. 1988. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 85(14): 5166-5170.
143. Scacheri PC, Crabtree JS, Novotny EA, Garrett-Beal L, Chen A, Edgemon KA, Marx SJ, Spiegel AM, Chandrasekharappa SC and Collins FS. 2001. Bidirectional transcriptional activity of Pgk-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 30(4): 259-263.
144. Schmidt-Supprian M, Wunderlich FT and Rajewsky K. 2007. excision of the Frt-flanked neo (R) cassette from the CD19cre knock-in transgene reduces Cre-mediated recombination. Transgenic Res 16(5): 657-660.
145. Schmidt EE, Taylor DS, Prigge JR, Barnett S and Capecchi MR. 2000. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97(25): 13702-13707.
146. Schulte-Merker S and Stainier DY. 2014. Out with the old, in with the new: reassessing morpholino knockdowns in light of genome editing technology. Development 141(16): 3103-3104.
147. Schwank G et al. 2013. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13(6): 653-658.
148. Schwartzberg PL, Goff SP and Robertson EJ. 1989. Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science 246(4931): 799-803.
149. Schwenk F, Sauer B, Kukoc N, Hoess R, Muller W, Kocks C, Kuhn R and Rajewsky K. 1997. Generation of Cre recombinase-specific monoclonal antibodies, able to characterize the pattern of Cre expression in cre-transgenic mouse strains. J Immunol Methods 207(2): 203-212.
150. Sebastiano V et al. 2011. In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells 29(11): 1717-1726.
151. Smithies O, Gregg RG, Boggs SS, Koralewski MA and Kucherlapati RS. 1985. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 317(6034): 230-234.
152. Sommer D et al. 2014. efficient genome engineering by targeted homologous recombination in mouse embryos using transcription activator-like effector nucleases. Nat Commun 5: 3045.
153. Spradling AC and Rubin GM. 1982. Transposition of cloned P elements into Drosophila germ line chromosomes. Science 218(4570): 341-347.
154. Sternberg N and Hamilton D. 1981. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150(4): 467-486.
155. Stolfi A, Gandhi S, Salek F and Christiaen L. 2014. Tissue-specific genome editing in Ciona embryos by Crispr/Cas9. Development 141(21): 4115-4120.
156. Straub C, Granger AJ, Saulnier JL and Sabatini BL. 2014. CRISPR/Cas9-mediated gene knock-down in post-mitotic neurons. PLoS One 9(8): e105584.
157. Sun Y, Chen X and Xiao D. 2007. Tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling. Acta Biochim Biophys Sin (Shanghai) 39(4): 235-246.
158. Sung YH, Baek IJ, Kim DH, Jeon J, Lee J, Lee K, Jeong D, Kim JS and Lee HW. 2013. Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol 31(1): 23-24.
159. Szczepek M, Brondani V, Buchel J, Serrano L, Segal DJ and Cathomen T. 2007. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol 25(7): 786-793.
160. Tamamaki N, Yanagawa Y, Tomioka R, Miyazaki J, Obata K and Kaneko T. 2003. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 467(1): 60-79.
161. Tang JC, Szikra T, Kozorovitskiy Y, Teixiera M, Sabatini BL, Roska B and Cepko CL. 2013. A nanobody-based system using fluorescent proteins as scaffolds for cell-specific gene manipulation. Cell 154(4): 928-939.
162. Thomas KR and Capecchi MR. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51(3): 503-512.
163. Thomas KR and Capecchi MR. 1990. Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 346(6287): 847-850.
164. Treen N, Yoshida K, Sakuma T, Sasaki H, Kawai N, Yamamoto T and Sasakura Y. 2013. Tissue-specific and ubiquitous gene knockouts by TALEN electroporation provide new approaches to investigating gene function in Ciona. Development 141(2): 481-487.
165. Tronche F, Casanova E, Turiault M, Sahly I and Kellendonk C. 2002. When reverse genetics meets physiology: the use of site-specific recombinases in mice. Febs Lett 529(1): 116-121.
166. Turan S and Bode J. 2011. Site-specific recombinases: from tag-and-target-to tag-and-exchange-based genomic modifications. FASEB J 25(12): 4088-4107.
167. Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD and Holmes MC. 2005. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435(7042): 646-651.
168. Urnov FD, Rebar EJ, Holmes MC, Zhang HS and Gregory PD. 2010. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11(9): 636-646.
169. Van Amerongen R, Bowman AN and Nusse R. 2012. Developmental stage and time dictate the fate of Wnt/beta-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 11(3): 387-400.
170. Venter JC et al. 2001. The sequence of the human genome. Science 291(5507): 1304-1351.
171. Vooijs M, Jonkers J and Berns A. 2001. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2(4): 292-297.
172. Wang H et al. 2013. TALEN-mediated editing of the mouse Y chromosome. Nat Biotechnol 31(6): 530-532.
173. Wang S, Sengel C, Emerson MM and Cepko CL. 2014. A gene regulatory network controls the binary fate decision of rod and bipolar cells in the vertebrate retina. Dev Cell 30(5): 513-527.
174. Wang X, Wang Y, WU X, Wang J, Wang Y, Qiu Z, Chang T, Huang H, Lin RJ and Yee JK. 2015. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol 33(2): 175-178.
175. Waterston RH et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420(6915): 520-562.
176. Watson JD and Crick FH. 1953. Genetical implications of the structure of deoxyribonucleic acid. Nature 171(4361): 964-967.
177. Whitehead AS and Sackstein R. 1985. Molecular biology of the human and mouse Mhc class Iii genes: phylogenetic conservation, genetics and regulation of expression. Immunol Rev 87: 185-208.
178. Wolfe SA, Nekludova L and Pabo CO. 2000. DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct 29: 183-212.
179. Wu L et al. 2003. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421(6926): 942-947.
180. Wu Y et al. 2014. Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells. Cell Res.
181. Xing HL, Dong L, Wang ZP, Zhang HY, Han CY, Liu B, Wang XC and Chen QJ. 2014. A CRISPR/Cas9 toolkit for multiplex genome editing in plants. BMC Plant Biol 14(1): 327.
182. Xu GL and Bestor TH. 1997. Cytosine methylation targetted to pre-determined sequences. Nat Genet 17(4): 376-378.
183. Xue Z, WU M, Wen K, Ren M, Long L, Zhang X and Gao G. 2014. CRISPR/Cas9 Mediates Efficient Conditional Mutagenesis in Drosophila. G3 (Bethesda) 4(11): 2167-2173.
184. Yamamoto M, Shook NA, Kanisicak O, Yamamoto S, Wosczyna MN, Camp JR and Goldhamer DJ. 2009. A multifunctional reporter mouse line for Cre-and FLP-dependent lineage analysis. Genesis 47(2): 107-114.
185. Yang H, Wang H, Shivalila CS, Cheng AW, Shi L and Jaenisch R. 2013. One-step generation of mice carrying reporter and conditional alleles by Crispr/Cas-mediated genome engineering. Cell 154(6): 1370-1379.
186. Yang M, Reynoso J, Jiang P, Li L, Moossa AR and Hoffman RM. 2004. Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors. Cancer Res 64(23): 8651-8656.
187. Yin H, Xue W, Chen S, Bogorad RL, Benedetti E, Grompe M, Koteliansky V, Sharp PA, Jacks T and anderson DG. 2014. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol 32(6): 551-553.
188. Yusa K et al. 2011. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478(7369): 391-394.
189. Zhang S, Li L, Kendrick SL, Gerard RD and Zhu H. 2014. TALEN-mediated somatic mutagenesis in murine models of cancer. Cancer Res 74(18): 5311-5321.
190. Zijlstra M, Li E, Sajjadi F, Subramani S and Jaenisch R. 1989. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342(6248): 435-438.